Page last updated: 2024-09-04

atrasentan and 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-

atrasentan has been researched along with 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- in 2 studies

Compound Research Comparison

Studies (atrasentan)	Trials (atrasentan)	Recent Studies (post-2010) (atrasentan)	Studies (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-)	Trials (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-)	Recent Studies (post-2010) (1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-)
358	41	108	123	3	1

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bal, R; Boyd, SA; Chiou, WJ; Dixon, DB; Hernandez, L; Jae, HS; Kester, JA; Mantei, RA; Marsh, KC; Novosad, EI; Opgenorth, TJ; Sorensen, BK; Tasker, AS; von Geldern, TW; Winn, M; Wu-Wong, JR	1
Dixon, DB; Jae, HS; Marsh, KC; Nguyen, B; Opgenorth, TJ; von Geldern, TW; Winn, M	1

Other Studies

2 other study(ies) available for atrasentan and 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-

Article	Year
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722. Journal of medicinal chemistry, 1996, Mar-01, Volume: 39, Issue:5 Topics: Animals; Aorta; Atrasentan; Biological Availability; Endothelin Receptor Antagonists; Endothelins; Hydrolysis; Male; Molecular Structure; Phosphatidylinositols; Pyrrolidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Structure-Activity Relationship; Vasoconstriction	1996
Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists. Journal of medicinal chemistry, 1997, Sep-26, Volume: 40, Issue:20 Topics: Administration, Oral; Animals; Atrasentan; Endothelin Receptor Antagonists; Half-Life; Male; Models, Chemical; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Structure-Activity Relationship	1997

Article

Year

2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.

Journal of medicinal chemistry, 1996, Mar-01, Volume: 39, Issue:5

Topics: Animals; Aorta; Atrasentan; Biological Availability; Endothelin Receptor Antagonists; Endothelins; Hydrolysis; Male; Molecular Structure; Phosphatidylinositols; Pyrrolidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Structure-Activity Relationship; Vasoconstriction

1996

Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists.

Journal of medicinal chemistry, 1997, Sep-26, Volume: 40, Issue:20

Topics: Administration, Oral; Animals; Atrasentan; Endothelin Receptor Antagonists; Half-Life; Male; Models, Chemical; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Structure-Activity Relationship

1997